Several anticancer agents, e.g. etoposide or 5-fluorouracil, however, predominantly induce apoptosis via a p53-dependent mechanism [30] and this action may render these agents less effective in p53-deficient osteosarcoma therapy. Here, TP53 is linked to osteosarcoma.